HOME >> BIOLOGY >> NEWS
Scientists Unlock Mystery Behind Proteins That Keep Tuberculosis Bacteria Alive; Finding Leads To Research Into New Drug Treatments

FORT COLLINS--Tuberculosis researchers have made a surprising discovery that puts a new twist on efforts to develop more effective drugs and vaccines against the infectious disease.

The discovery, made by scientists at Colorado State University's Mycobacteria Research Laboratory, centers around a group of proteins that scientists have studied for years. However, past research has focused solely on how these proteins, called antigen 85, help defend the body against TB. Antigen 85 activates the immune system after a person is exposed to mycobacterium tuberculosis, the bacteria that causes the disease.

But recently, microbiologists John Belisle, Varalakshmi Vissa and Gurdyal Besra discovered the set of proteins has another face. Antigen 85 also plays a key role in protecting the tuberculosis bacteria from drugs, an unexpected finding that can help develop new treatments that specifically inhibit this function.

"When we confirmed what we had, we were shocked," Belisle said. "This is a major protein that has been studied widely for years in relation to its protective capabilities against TB. It wasn't until we purified the proteins associated with this enzymatic activity that we realized antigen 85 has two very different roles."

In the study, Belisle and his colleagues confirmed that antigen 85 also functions as an enzyme in forming and maintaining the TB bacteria's waxy and tough cell wall, which is composed of intricately linked mycolic acids. This tight web makes the cell wall virtually impermeable to many drugs, making the disease difficult to treat.

In addition, the team's study identified key regions of antigen 85 proteins that are responsible for these important enzymatic activities. Now that it's known what areas of the proteins carry out their designated function, the researchers now are working with two pharmaceutical companies to create drugs that "turn off" antigen 85's role in keeping the bacteria aliv
'"/>

Contact: Carrie Schafer
CSchafer@vines.colostate.edu
(970) 491-6432
Colorado State University
13-Aug-1997


Page: 1 2

Related biology news :

1. Scientists to prototype cyberinfrastructure for research and education access to ocean observatories
2. Scientists sequence genome of kind of organism central to biospheres carbon cycle
3. Scientists find nanowires capable of detecting individual viruses
4. Scientists discover potential new way to control drug-resistant bacteria
5. Scientists explore genome of methane-breathing microbe
6. Scientists decipher genetic code of biothreat pathogen
7. Stuck on you: Scientists lay bare secrets of bacterial attachment proteins
8. Scientists discover proteins involved in spread of HIV-1 infection
9. Scientists fear new Ebola outbreak may explain sudden gorilla disappearance
10. Scientists reinvent DNA as template to produce organic molecules
11. Scientists visualise cellular handmaiden that restores shape to proteins

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/5/2017)... April 5, 2017 Today HYPR Corp. ... the server component of the HYPR platform is officially ... the end-to-end security architecture that empowers biometric authentication across ... has already secured over 15 million users across the ... of connected home product suites and physical access represent ...
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
(Date:3/30/2017)... March 30, 2017 Trends, opportunities and forecast ... behavioral), by technology (fingerprint, AFIS, iris recognition, facial recognition, ... others), by end use industry (government and law enforcement, ... and banking, and others), and by region ( ... Asia Pacific , and the Rest ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... The ... endogenous context, enabling overexpression experiments and avoiding the use of exogenous expression plasmids. ... is transformative for performing systematic gain-of-function studies. , This complement to loss-of-function ...
(Date:10/11/2017)... the Netherlands and LAGUNA HILLS, Calif. ... The Institute of Cancer Research, London ... use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients ... trial known as MUK nine . The University of ... trial, which is partly funded by Myeloma UK, and ICR ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... (ADC) therapeutics, today confirmed licensing rights that give it exclusive global access ... developed in collaboration with Children’s Hospital Los Angeles (CHLA). Additionally, an ...
(Date:10/10/2017)... ... October 10, 2017 , ... USDM Life Sciences ... the life sciences and healthcare industries, announces a presentation by Subbu Viswanathan and ... presentation, “Automating GxP Validation for Agile Cloud Platforms,” will present a revolutionary approach ...
Breaking Biology Technology:
Cached News: